Calzada Limited is a Melbourne based biotechnology company which owns 100% of PolyNovo Biomaterials Pty Ltd, an innovative biodegradeable polymer technology company, and 100% of Metabolic Pharmaceuticals Pty Ltd which holds the AOD9604 intellectual property for the treatment of obesity and bone disorders. The company is listed on the Australian Stock Exchange, ASX code: CZD